Work

Improving Capillary Blood Glucose Monitoring in Respiratory Inpatients Receiving High-Dose Systemic Corticosteroids: A Quality Improvement Study

Year: 2026
Type: article
Abstract: Introduction Systemic corticosteroids can cause hyperglycemia, making appropriate inpatient capillary blood glucose (CBG) monitoring important. This quality improvement project aimed to increase adherence to Joint British Diabetes Societies for Inpatient Care (JBDS-IP) monitoring recommendations from 28.1% to at least 70% within six weeks on two respiratory wards. Materials and methods A prospective quality improvement project was conducted at Ulster Hospital, Northern Ireland, from September to October 2026. Guideline-appropriate CBG monitoring was assessed using eligible patient-days. Two sequential Plan-Do-Study-Act (PDSA) cycles introduced ward-based nursing education, followed by a prompt for doctors to document once-daily or four-times-daily (QDS) monitoring requirements in the electronic medical review plan. Outcome, process, and balancing measures were analyzed descriptively. Results Across 224 eligible patient-days, guideline-appropriate CBG monitoring increased from 16/57 (28.1%) at baseline to 65/89 (73.0%) following Cycle 1 and 70/78 (89.7%) following Cycle 2. Complete QDS monitoring among patients with pre-existing diabetes increased from 0/9 (0%) to 7/16 (43.8%) and 6/8 (75.0%), respectively. However, unnecessary additional monitoring increased from 6.7% at baseline to 26.2% following Cycle 2, while recorded escalation following elevated glucose readings remained limited. Conclusions Nursing education and electronic documentation prompts were associated with improved adherence to guideline-recommended CBG monitoring. Longer-term evaluation is required to assess sustainability. Future improvement efforts should focus on appropriate escalation following elevated readings and reducing unnecessary monitoring.
Source: Cureus
Institution: Ulster Hospital
Language: English
Field: Medicine
Open Access status: diamond
OpenAlex ID: W7234716874
FWCI:
Cites: 16
Cited by:
Related to: 10